Aishwarya Mathew

Mastered contemporary concepts and techniques employed in the biotechnology and pharmaceutical sectors. Directed the transition of drug substances into products, advancing them through clinical development and onto market launch. Cultivated in-depth knowledge of biopharmaceutical quality assurance and control standards. Developed knowledge in mammalian cell biotechnology.

Engineered and refined ELISA methodologies for monoclonal antibodies, leveraging computational tools like Softmax Pro software. Crafted and certified a Blockade bioassay technique and handled routine mammalian cell culture processes, such as cell revival, subculturing, and sustaining cell lines for use in potency-oriented cell-based assays. Coordinated inventory control, upheld safety standards as a member of the Emergency Response Team, and ensured adherence to quality and cGMP protocols.